Evidence map›Paper›PMID 30659097›Full record

ArticleThe Journal of biological chemistry2019

Hepatitis B virus X protein-induced SH2 domain-containing 5 (SH2D5) expression promotes hepatoma cell growth via an SH2D5-transketolase interaction.

Yongfa Zheng, Pingpo Ming, Chengliang Zhu, Yu Si, Shilei Xu, Aidong Chen, Jun Wang, Binghong Zhang

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. The FirstMicroorganisms · 2022
    Article
  16. JMJD3 PromotesDNA and cell biology · 2022
    Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Yongfa ZhengFrom the Departments of Oncology.
Pingpo MingFrom the Departments of Oncology.
Chengliang ZhuClinical Laboratory, and.
Yu Sithe Department of Otolaryngology-Head and Neck Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120.
Shilei Xuthe Department of General Surgery, Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong 510530.
Aidong Chenthe Department of Physiology, Nanjing Medical University, Nanjing 211166, and.
Jun Wangthe Center of Clinical Laboratory, Fifth People's Hospital of Wuxi, affiliated with Jiangnan University, Wuxi, Jiangsu 214005, China.
Binghong ZhangNeonatology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, binghongzhangrm@126.com.
Wuhan University · CNSun Yat-sen University · CNJiangnan University · CNNanjing Medical University · CNRenmin Hospital of Wuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatitis B virus X protein (HBx) critically contributes to the development of hepatocellular carcinoma (HCC). However, the mechanisms by which HBx promotes HCC remain unclear. In the present study, using a combination of gene expression profiling and immunohistochemistry, we found higher levels of SH2 domain-containing 5 (SH2D5) in liver tissue from HBV-associated HCC (HBV-HCC) patients than in adjacent nontumor tissues. Moreover, HBV infection elevated SH2D5 levels, and we observed that HBx plays an important role in SH2D5 induction. We also found that HBx triggers SH2D5 expression through the NF-κB and c-Jun kinase pathways. Employing SH2D5 overexpression or knockdown, we further demonstrate that SH2D5 promotes HCC cell proliferation both

Indexed as

Gene Expression Regulation, EnzymologicGene Expression Regulation, NeoplasticCarcinoma, HepatocellularHepatitis BHepatitis B virusHep G2 CellsHumansLiver NeoplasmsNF-kappa BProto-Oncogene Proteins c-junShc Signaling Adaptor ProteinsSTAT3 Transcription FactorTrans-ActivatorsTransketolaseViral Regulatory and Accessory Proteinshepatitis B virus X proteinNF-kappa BProto-Oncogene Proteins c-junShc Signaling Adaptor ProteinsSTAT3 Transcription FactorTrans-ActivatorsTransketolaseViral Regulatory and Accessory Proteinscancer biologycell migrationHBV-associated HCCHBV X proteinhepatitis B virus (HBV, Hep B)IL-6-STAT3 signalinginflammationinterleukin 6 (IL-6)SH2D5transketolase

Identifiers

PMID30659097
PMCPMC6442033
OpenAlexW2909321623

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.